HistoSonics has completed patient enrollment in a pivitol clinical trial to evaluate its Edison histotripsy system in ...

The future of non-invasive cancer therapy is bright. Liver tumors can now be destroyed—without radiation, chemotherapy or surgery—thanks to new medical technology known as histotripsy.

The urology ultrasound devices market is projected to grow at a CAGR of 6%, driven by the rising prevalence of urological ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

Virginia Tech researchers are developing more precise treatments for pediatric brain cancer using a new class of therapies ...

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today ...

The 'Bachelorette' alum shared an update in her ongoing breast cancer struggle as she's "trying to live my best life as a ...

Buddhist temples in China are home to trees from dozens of endangered species, a new study shows. Some of them are almost ...

The Edison system was one of just eight available application spots for the U.K. market in 2024, HistoSonics said.

The deviant behavior of a subatomic particle might point to undiscovered forms of matter and energy in the universe. Or it ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...